News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,461 Results
Type
Article (41709)
Company Profile (310)
Press Release (658442)
Section
Business (209993)
Career Advice (2067)
Deals (36574)
Drug Delivery (91)
Drug Development (82736)
Employer Resources (170)
FDA (16443)
Job Trends (15347)
News (354994)
Policy (33805)
Tag
Academia (2576)
Africa (777)
Alliances (51032)
Alzheimer's disease (1180)
Approvals (16370)
Arizona (186)
Artificial intelligence (96)
Asia (39775)
Australia (6350)
Bankruptcy (361)
Best Places to Work (11495)
Biosimilars (70)
Biotechnology (200)
Breast cancer (77)
C2C Services and Suppliers (79758)
California (2177)
Canada (1030)
Cancer (659)
Career advice (1729)
Cell therapy (158)
China (172)
Clinical research (65038)
Collaboration (207)
Colorado (91)
Compensation (127)
Connecticut (95)
COVID-19 (2574)
Cystic fibrosis (80)
Data (495)
Diabetes (100)
Diagnostics (6099)
Drug pricing (82)
Earnings (85404)
Employer resources (145)
Europe (84646)
Events (111041)
Executive appointments (200)
FDA (16763)
Florida (316)
Funding (197)
Gene therapy (117)
GLP-1 (559)
Government (4427)
Healthcare (18809)
Hotbed/Location (489837)
Illinois (284)
Indiana (164)
Infectious disease (2620)
Inflammatory bowel disease (97)
Interviews (318)
IPO (16505)
Job creations (4052)
Job search strategy (1486)
Kansas (94)
Layoffs (420)
Legal (8303)
Lung cancer (126)
Manufacturing (122)
Maryland (449)
Massachusetts (1808)
Medical device (13170)
Medtech (13175)
Mergers & acquisitions (19990)
Metabolic disorders (307)
Michigan (133)
Minnesota (231)
Neuroscience (1376)
New Jersey (676)
New York (678)
NextGen Class of 2024 (6616)
Non-profit (4508)
North Carolina (628)
Northern California (941)
Obesity (186)
Ohio (115)
Opinion (196)
Patents (83)
Pennsylvania (642)
People (57944)
Pharmaceutical (91)
Phase I (20066)
Phase II (28598)
Phase III (21517)
Pipeline (145)
Postmarket research (2643)
Preclinical (8537)
Radiopharmaceuticals (235)
Rare diseases (158)
Real estate (6238)
Regulatory (22138)
Research institute (2360)
Resumes & cover letters (356)
South America (1162)
Southern California (879)
Startups (3713)
Texas (294)
United States (9768)
Vaccines (515)
Washington State (274)
Weight loss (153)
Date
Today (149)
Last 7 days (607)
Last 30 days (2703)
Last 365 days (37283)
2024 (28131)
2023 (40644)
2022 (51822)
2021 (56350)
2020 (54813)
2019 (47443)
2018 (35797)
2017 (33156)
2016 (32696)
2015 (38658)
2014 (32537)
2013 (27649)
2012 (29743)
2011 (30502)
2010 (28521)
700,461 Results for "horizon pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons
Ora, Inc. announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology 2024 conference, and as host and convener of the Dry Horizons Symposium in partnership with Ophthalmology Innovation Source.
May 1, 2024
·
5 min read
Press Releases
GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
September 12, 2024
·
4 min read
Biotech Bay
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a panel on “Breast Cancer – Shifting an Entrenched Paradigm” at the 2024 CG Horizons in Oncology Virtual Conference on Monday, April 15, 2024, at 2:00 p.m. ET.
April 8, 2024
·
1 min read
Biotech Bay
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer will participate in a panel at the Canaccord Genuity Horizons in Oncology Virtual Conference being held April 15, 2024.
April 8, 2024
·
1 min read
Biotech Bay
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
RenovoRx, Inc today announced that Shaun Bagai, RenovoRx’s Chief Executive Officer, will present at the Canaccord Genuity 2024 Horizons in Oncology Virtual Conference to be held on April 15, 2024.
April 5, 2024
·
7 min read
Press Releases
ONI Expands Horizons: Entering the Lipid Nanoparticle Research Market
September 17, 2024
·
2 min read
Press Releases
Pharmaceutical Excipients Market Size to Surge to US$ 14.72 Billion by 2033, Unlocking New Growth Horizons
August 7, 2024
·
13 min read
Press Releases
Horizon Technology Finance Provides $35 Million Venture Loan Facility to GT Medical Technologies
September 12, 2024
·
4 min read
Press Releases
Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis
September 26, 2024
·
8 min read
Drug Development
Beacon Therapeutics Presents 36-Month Interim Results from Phase I/2 HORIZON Trial of AGTC-501 in Patients with XLRP
September 19, 2024
·
2 min read
1 of 70,047
Next
